Trusted by 100,000+ International Patients
HIPEC: Malaysia vs Turkey
Cost, Quality & Recovery Compared
$83680
Malaysia Starting Cost
$28500
Turkey Starting Cost
See how these top medical tourism destinations compare for HIPEC.
| Comparison Factor | Malaysia | Turkey | Winner |
|---|---|---|---|
| Average Cost (in USD) | 83680 - 44478 | 28500 - 40000 | Turkey |
| Success Rate (Min and Max) | 55% – 80% | 52% – 78% | Malaysia |
| Advanced Technology | Advanced CRS + HIPEC programs in specialised oncology centres with modern perfusion systems, PET-CT imaging, and minimally invasive/robotic-assisted surgical support | Tertiary surgical oncology hospitals with CRS+HIPEC capability and structured ICU pathways in major centres. | Both Equal |
| JCI Accredited Hospitals | 10+ | 25+ | Turkey |
| Visa Process | Medical Visa / eVisa / eNTRI (2–5 working days) | Medical Visa / e-Visa (5-10 days depending on nationality) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Top Hospitals: Liv Hospital Ulus , Medicana Camlica Hospital , Medicana Bahcelievler Hospital , Acibadem Hospital Taksim
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth Malaysia and Turkey maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
Many hospitals in Malaysia are accredited by JCI and MSQH with specialised oncology and surgical units.
HIPEC outcomes depend on cancer type, stage, and completeness of cytoreduction; Malaysian centres follow international oncology protocols and multidisciplinary tumour board approaches.
Healthcare is regulated by the Ministry of Health Malaysia (MOH) and Malaysian Society for Quality in Health (MSQH), ensuring strict standards for oncology care and surgical safety.
25+ JCI-accredited hospitals and internationally recognised tertiary oncology centres.
Comparable tertiary centres follow European-aligned surgical oncology protocols for CRS+HIPEC.
Regulated under the Turkish Ministry of Health, oncology centres operate under national governance and drug safety standards.
| Quality Metric | Malaysia | Turkey |
|---|---|---|
Accredited Hospitals | 10+ | 25+ |
CRS + HIPEC Availability | Yes | Yes |
ICU Support Level | Advanced (tertiary ICUs) | Advanced (tertiary) |
Top Speciality Hospital Hubs | Kuala Lumpur, Penang | Istanbul, Ankara |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Highly specialised surgical oncologists
Moderate to high volume
Cancer Specialist
Concentrated in tertiary oncology hospitals; experience varies by centre.
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Leading hospitals in Malaysia feature advanced operating theatres, specialised HIPEC perfusion systems, surgical oncology ICUs, and integrated cancer care services including molecular diagnostics, pathology, and advanced imaging technologies.
Luxury healthcare experience
Major oncology hospitals in Turkey are equipped with modern operating theatres, HIPEC perfusion technology for heated intraperitoneal chemotherapy, dedicated surgical oncology ICUs, advanced imaging (PET-CT, MRI), and integrated pathology and oncology pharmacy services. These facilities support comprehensive multidisciplinary cancer treatment.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after HIPEC in both countries.
HIPEC is performed along with cytoreductive surgery to remove visible tumours and treat microscopic disease.
Patients require ICU monitoring immediately after surgery.
International patients are advised to stay locally for recovery and follow-up.
Recovery improves gradually with nutrition, physiotherapy, and oncology care.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
HIPEC is performed during cytoreductive surgery (CRS), where heated chemotherapy is circulated inside the abdominal cavity after tumour removal.
Patients usually require ICU monitoring immediately after surgery.
A short local stay after discharge is recommended for wound care, nutritional support, and recovery monitoring.
Recovery progresses gradually with dietary management, physiotherapy, and oncology follow-up visits.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
HIPEC recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your HIPEC journey.
Higher surgical risk due to extensive tumour removal; managed in specialised ICU settings.
Expected after major abdominal surgery; controlled with pain management protocols.
Possible due to nutritional status; requires dietary and medical support.
Risk of bowel-related complications or infection, depending on the surgical extent.
Chemotherapy exposure may affect the kidneys and bone marrow; it requires monitoring.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients with peritoneal malignancies such as colorectal cancer with peritoneal spread, ovarian cancer, appendix tumours, peritoneal mesothelioma, or pseudomyxoma peritonei are suitable for cytoreductive surgery with HIPEC.
Patients diagnosed with peritoneal surface malignancies, including colorectal cancer metastasis to the peritoneum, ovarian cancer, appendiceal cancer, or pseudomyxoma peritonei, who may benefit from cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC).
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your HIPEC journey.
Doctors evaluate disease extent using PCI scoring and imaging.
Surgeons assess whether complete tumour removal is possible.
Plan ICU stay and post-operative monitoring.
Budget for surgery, hospitalisation, and possible complications.
Schedule oncology follow-up and additional treatments if required.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
